Notably, the cardioprotective effects of Sig-1R modulation are evident in preclinical models of myocardial IRI, HF, hypertrophy, cardiac fibrosis, cardiomyopathy, depression, ER stress, and COVID-19. The gene discussed is SIGMAR1; the disease is major depressive disorder.